JP2023510911A5 - - Google Patents
Info
- Publication number
- JP2023510911A5 JP2023510911A5 JP2022543472A JP2022543472A JP2023510911A5 JP 2023510911 A5 JP2023510911 A5 JP 2023510911A5 JP 2022543472 A JP2022543472 A JP 2022543472A JP 2022543472 A JP2022543472 A JP 2022543472A JP 2023510911 A5 JP2023510911 A5 JP 2023510911A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- item
- target
- biomarker
- women
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062962711P | 2020-01-17 | 2020-01-17 | |
| US62/962,711 | 2020-01-17 | ||
| US202063049063P | 2020-07-07 | 2020-07-07 | |
| US63/049,063 | 2020-07-07 | ||
| PCT/US2021/013776 WO2021146659A1 (en) | 2020-01-17 | 2021-01-16 | Compositions and methods for detection of ovarian cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023510911A JP2023510911A (ja) | 2023-03-15 |
| JP2023510911A5 true JP2023510911A5 (enExample) | 2024-01-23 |
Family
ID=76864515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022543472A Pending JP2023510911A (ja) | 2020-01-17 | 2021-01-16 | 卵巣癌を検出するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230243834A1 (enExample) |
| EP (1) | EP4090767A4 (enExample) |
| JP (1) | JP2023510911A (enExample) |
| KR (1) | KR20220129591A (enExample) |
| CN (1) | CN115279920A (enExample) |
| AU (1) | AU2021209128A1 (enExample) |
| CA (1) | CA3167721A1 (enExample) |
| WO (1) | WO2021146659A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113748217B (zh) * | 2019-03-01 | 2023-08-25 | 仁慈生物分析公司 | 用于靶实体检测的系统、组合物和方法 |
| CA3202255A1 (en) | 2020-12-21 | 2022-06-30 | Hayley WARSINSKE | Markers for the early detection of colon cell proliferative disorders |
| EP4427050A4 (en) * | 2021-11-03 | 2025-10-29 | Toreador Therapeutics Inc | METHODS AND SYSTEMS FOR SUPER-RESOLUTION STUDYING OF THERAPIES |
| JP2024543085A (ja) * | 2021-11-17 | 2024-11-19 | マーシー バイオアナリティクス， インコーポレイテッド | 卵巣がんの検出のための組成物および方法 |
| KR102573076B1 (ko) * | 2022-01-25 | 2023-09-01 | 주식회사 베르티스 | 난소암의 진단용 신규 바이오마커 |
| JP2023154548A (ja) * | 2022-04-07 | 2023-10-20 | 国立大学法人東海国立大学機構 | 卵巣癌を検査する方法 |
| CN116434833A (zh) * | 2023-03-16 | 2023-07-14 | 重庆医科大学 | 一种卵巢癌相关的分子标记及其筛选方法与应用 |
| CN119530380A (zh) * | 2023-08-31 | 2025-02-28 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种上皮性卵巢癌的生物标志物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3730618A1 (en) * | 2011-11-18 | 2020-10-28 | Alnylam Pharmaceuticals, Inc. | Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases |
| AU2013361323B2 (en) * | 2012-12-19 | 2018-09-06 | Caris Science, Inc. | Compositions and methods for aptamer screening |
| WO2015185730A2 (en) * | 2014-06-06 | 2015-12-10 | Hansabiomed Ou | Exosomal biomarkers |
| US12480940B2 (en) * | 2018-05-17 | 2025-11-25 | Meso Scale Technologies, Llc. | Methods for isolating surface marker displaying agents |
-
2021
- 2021-01-16 US US17/793,382 patent/US20230243834A1/en active Pending
- 2021-01-16 AU AU2021209128A patent/AU2021209128A1/en active Pending
- 2021-01-16 CA CA3167721A patent/CA3167721A1/en active Pending
- 2021-01-16 JP JP2022543472A patent/JP2023510911A/ja active Pending
- 2021-01-16 CN CN202180019123.8A patent/CN115279920A/zh active Pending
- 2021-01-16 EP EP21740895.4A patent/EP4090767A4/en active Pending
- 2021-01-16 WO PCT/US2021/013776 patent/WO2021146659A1/en not_active Ceased
- 2021-01-16 KR KR1020227028296A patent/KR20220129591A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510911A5 (enExample) | ||
| JP2022521781A5 (enExample) | ||
| JP2023533970A5 (enExample) | ||
| JP7344973B2 (ja) | 標的実体を検出するためのシステム、組成物、及び方法 | |
| Stelloo et al. | High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma | |
| US11130789B2 (en) | Urine markers for detection of bladder cancer | |
| Rimsza et al. | Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues | |
| US20230243834A1 (en) | Compositions and methods for detection of ovarian cancer | |
| KR20160134817A (ko) | 암 치료 | |
| Tu et al. | Electric field–induced release and measurement (EFIRM): characterization and technical validation of a novel liquid biopsy platform in plasma and saliva | |
| JP2025504786A5 (enExample) | ||
| Song et al. | 5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation | |
| JP2021517250A (ja) | 自己抗体−抗原結合体を利用した肺癌診断用免疫学的組成物、これを用いた肺癌診断方法及びこれを含む肺癌診断用キット | |
| JPWO2019221279A1 (ja) | 前立腺癌を判定する方法 | |
| Yazaki‐Sun et al. | Correlation of c‐erbB‐2 oncogene and p53 tumor suppressor gene with malignant transformation of hydatidiform mole | |
| Qui et al. | Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum | |
| CN108913772B (zh) | 基于捕获测序的bMSI检测技术 | |
| Thway et al. | The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma | |
| US20220064235A1 (en) | Urine Markers and Methods for Detection of Bladder Cancer and Treatment Thereof | |
| Vural et al. | KRAS mutations: a possible biomarker for advanced prostate cancer | |
| JP2024529918A5 (enExample) | ||
| CN101236193A (zh) | 胃癌的淋巴结转移的检测 | |
| AU2015255160A1 (en) | Urine markers for detection of bladder cancer | |
| RU2813669C1 (ru) | Способ неинвазивной диагностики рака мочевого пузыря на основе выявления опухолевой днк в биологических жидкостях и набор реагентов для его осуществления | |
| US20250101529A1 (en) | Multimodal detection with extracellular vesicles |